Selection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer

被引：3

作者：

Koenigsrainer, Ingmar ^{[1
]}

机构：

[1] Univ Tubingen Hosp, Dept Gen Visceral & Transplant Surg, D-72076 Tubingen, Germany

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2011年 / 17卷 / 37期

关键词：

Peritoneal carcinomatosis; Gastric cancer; Hyperthermic intraperitoneal chemotherapy; Cytoreductive surgery; Selection criteria; PHOSPHOGLYCERATE KINASE 1; PERITONEAL CARCINOMATOSIS; DISSEMINATION; THERAPY;

D O I：

10.3748/wjg.v17.i37.4153

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Peritoneal carcinomatosis in gastric cancer is associated with a dismal prognosis. Systemic chemotherapy is not effective because of the existence of a blood-peritoneal barrier. Cytoreductive surgery and intraperitoneal chemotherapy can improve survival and quality of life in selected patients. Patient selection for this multimodal approach is one of the most critical issues, and calls for interdisciplinary evaluation by radiologists, medical and surgical oncologists, and anaesthetists. This article sets forth criteria for selection of gastric cancer patients suffering from peritoneal carcinomatosis. (C) 2011 Baishideng. All rights reserved.

引用

页码：4153 / 4156

页数：4

共 50 条

[31] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer with Peritoneal Metastasis-Indian Experience
Somashekhar, S. P.
Karivedu, Jyothsana
Kumar, Rohit C.
Ramya, Y.
Kapoor, Priya
Rauthan, Amit
Ashwin, K. R.
SOUTH ASIAN JOURNAL OF CANCER, 2022, 11 (02) : 121 - 124
[32] Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer
Braam, H. J.
Schellens, J. H.
Boot, H.
van Sandick, J. W.
Knibbe, C. A.
Boerma, D.
van Ramshorst, B.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 95 (03) : 282 - 296
[33] Peritoneal metastases from colorectal cancer: Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Riss, S.
Mohamed, F.
Dayal, S.
Cecil, T.
Stift, A.
Bachleitner-Hofmann, T.
Moran, B.
EJSO, 2013, 39 (09): : 931 - 937
[34] Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Carcinomatosis: Additional Information Helps to Optimize Patient Selection before Surgery
Hung, Hao-Chien
Hsu, Po-Jung
Lee, Chao-Wei
Hsu, Jun-Te
Wu, Ting-Jung
CANCERS, 2023, 15 (07)
[35] Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Gallbladder Cancer: A Retrospective Review
Randle, Reese W.
Levine, Edward A.
Clark, Clancy J.
Stewart, John H.
Shen, Perry
Votanopoulos, Konstantinos I.
AMERICAN SURGEON, 2014, 80 (07) : 710 - 713
[36] The Role of Cytoreductive Surgery and Intraperitoneal Chemotherapy in Gastric Cancer
Young, Stephanie
Ostowari, Arsha
Yu, Jingjing
Eng, Oliver S.
Dayyani, Farshid
Senthil, Maheswari
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (11) : 673 - 682
[37] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian cancer: opportunity and obligations
Miner, Thomas J.
13TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI) HELD JOINTLY WITH THE GERMAN SOCIETY OF OBSTETRICS & GYNECOLOGY, 2010, : 37 - 39
[38] Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
Helm, C. William
Bristow, Robert E.
Kusamura, Shigeki
Baratti, Dario
Deraco, Marcello
JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (04) : 283 - 290
[39] Peritoneal metastatic colorectal Cancer: cytoreductive Surgery and hyperthermic intraperitoneal Chemotherapy
Koenigsrainer, I.
Beckert, S.
Bruecher, B.
Zieker, D.
Koenigsrainer, A.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (36) : 1811 - 1814
[40] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian cancer: World experience
Helm, C. William
Intraperitoneal Cancer Therapy, 2007, : 147 - 161

← 1 2 3 4 5 →